See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI101.19▲ 1.73%
← 0LBP page
XStocksXray
Market X-Ray report · 22 October 2026

Synopsys Inc. (0LBP)

London Exchange · UK · prices in USD · close of 22 Oct 2026

Key indicators

Last closeUSD 428.20
52-week range362.68 – 540.00
Return, 1 month / 3 months+4.2% / +13.4%
Return, 1 year / 3 years−6.3% / −9.2%
TrendBelow its 200-day average
RSI (14)42
Volatility (1 year)45.0%
Worst drawdown (1 year)-31.5%
Average daily value traded1.23M USD
Dividend yield–

Market X-Ray price-based

45/ 100 · High confidence · ahead of 37% of stocks on this exchange
Trend40
Momentum48
Stability (higher is calmer)39
Liquidity55
Income–

Five-year price chart navy: price · brown: 200-day average

2413494575656732021-102023-012024-052025-082026-10

About the company

Synopsys provides software and services used to design and verify semiconductors and electronic systems. Its tools help engineers create and test integrated circuits, and it supplies pre-designed circuit building blocks that chipmakers license for their own products. It also offers tools for testing software security and quality. Customers are mainly chipmakers, electronics firms and software developers around the world, and the company is based in California in the United States.

On this site Synopsys Inc. appears as a stock on the London Exchange (UK), code 0LBP, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Synopsys Inc. (0LBP) trades on the London Exchange in UK. It last closed at USD 428.20 on 22 October 2026.

Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 2,373 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 6.3% and over the last three months it rose 13.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Synopsys Inc. (0LBP)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend40 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-3.7%
From 52-week high-19.7%
Momentum48 · WeakLagging most stocks on this exchange.
3-month return13.4%
6-month return-9.6%
12-month return, skipping the last month-10.0%
Stability (higher is calmer)39 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)45.0%
Worst drawdown, 1 year (smaller is calmer)-31.5%
Liquidity55 · FairModerate trading activity.
Average daily value traded1.23M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−7.3%
1 month+4.2%
3 months+13.4%
6 months−9.6%
1 year−6.3%
3 years−9.2%
5 years+32.2%

Signals

50-day / 200-day average430.79 / 444.58
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)20.90

Technical summary

DailyBearish3 bullish · 2 neutral · 11 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026